Biocept, Inc.
5810 Nancy Ridge Drive
San Diego, CA 92121
(858) 320-8200
December 5, 2019
Via Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:Chris Edwards
Re:Biocept, Inc.
Registration Statement on Form S-1
File No. 333-234459
Acceleration Request
Requested Date:Friday, December 6, 2019
Requested Time:9:05 a.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, Biocept, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective at 9:05 a.m. Eastern Time on Friday, December 6, 2019, or as soon thereafter as is practicable. This request for acceleration is subject, however, to your receiving a telephone call prior to such time from the Registrant’s legal counsel, Cooley llp, confirming this request. The Registrant also hereby requests a copy of the written order verifying the effective date.
If you have any questions regarding this request, please contact Charles J. Bair of Cooley llp at (858) 550-6142 or Asa M. Henin of Cooley llp at (858) 550-6104.
Sincerely,
Biocept, Inc.
By: /s/ Timothy Kennedy
Timothy Kennedy
Chief Financial Officer and
SVP Operations
